Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of rivaroxaban versus
fondaparinux in the treatment of superficial vein thrombosis (SVT).